|
Real-time Estimate
Cboe BZX
10:08:05 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 2.255 USD | -4.45% |
|
-7.73% | +26.11% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 2026-08-10 | 2026-08-11 | 2026-08-12 | 2026-08-13 | 2026-08-14 | |
|---|---|---|---|---|---|
| Last | US$2.480 | US$2.430 | US$2.620 | US$2.360 | US$2.265 |
| Volume | 773,425 | 373,852 | 2,012,469 | 2,001,846 | 252,550 |
| Change | +0.81% | -2.02% | +7.82% | -9.92% | -4.45% |
| Opening | US$2.480 | US$2.470 | US$2.490 | US$2.640 | US$2.360 |
| High | US$2.500 | US$2.480 | US$2.705 | US$2.640 | US$2.360 |
| Low | US$2.410 | US$2.410 | US$2.400 | US$2.320 | US$2.265 |
Performance
| 1 day | -4.45% | ||
| 1 week | -7.73% | ||
| Current month | -4.22% | ||
| 1 month | -1.74% | ||
| 3 months | +13.50% | ||
| 6 months | -23.83% | ||
| Current year | +26.11% | ||
| 1 year | +49.34% | ||
| 3 years | +14.07% | ||
| 5 years | +71.96% | ||
| 10 years | -64.97% |
Volumes
marketsDaily volume
252,550
Estimated daily volume
4,212,167
Avg. Volume 20 sessions
688,823
Daily volume ratio
6.12
Avg. Volume 20 sessions USD
1,553,295.87
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
190,149,075
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
182,775,482
Average Daily Capital Traded
0.82%
Indicators
Moving average 5 days
2.47
Moving average 20 days
2.388
Moving average 50 days
2.268
Moving average 100 days
2.198
Price spread / (MMA5)
+9.53%
Price spread / (MMA20)
+5.92%
Price spread / (MMA50)
+0.58%
Price spread / (MMA100)
-2.53%
STIM
RSI 9 days
73.62
RSI 14 days
69.06
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.45% | -7.73% | +49.34% | +14.07% | 190M | |
| -2.01% | -0.79% | +71.87% | +118.65% | 1,078B | |
| -0.57% | +0.40% | +48.96% | +50.06% | 632B | |
| -0.35% | +1.02% | +21.43% | +63.23% | 443B | |
| -2.40% | -3.76% | +41.34% | +33.47% | 356B | |
| -1.79% | -3.67% | +23.12% | +33.48% | 289B | |
| -2.18% | -3.65% | -1.07% | +3.13% | 245B | |
| -1.13% | +0.15% | +41.77% | +57.70% | 226B | |
| -0.82% | -2.65% | -8.47% | -52.04% | 204B | |
| -0.79% | +2.82% | +15.08% | +71.53% | 171B | |
| Average | -1.68% | +0.96% | +30.34% | +39.33% | 364.39B | |
| Weighted average by Cap. | -1.43% | +1.30% | +40.98% | +61.63% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
ed159c182ef60d8.DoIyCqiZdAQhxgu2lcW-8piC9eoO4D0TvLYVG8ReKuU.P7ZaQ9HKEH1VonrV-7DKsfW2nIJekURFj4RnK6xrfbY7sUpl98A6QWauZA
| Date | Price | Volume | Total |
|---|---|---|---|
| 09:52:46 | 2.265 | 100 | 242,614 |
| 09:52:04 | 2.270 | 100 | 242,514 |
| 09:51:37 | 2.270 | 300 | 242,414 |
| 09:50:03 | 2.270 | 500 | 242,114 |
| 09:50:03 | 2.270 | 500 | 241,614 |
| 09:50:03 | 2.270 | 500 | 241,114 |
| 09:49:22 | 2.265 | 140 | 240,614 |
| 09:49:05 | 2.270 | 180 | 240,474 |
| 09:49:05 | 2.270 | 100 | 240,294 |
| 09:49:05 | 2.270 | 200 | 240,194 |
Course Extremes
| 1 week | 2.26 |  | 2.7 |
| 1 month | 2.2 | | 2.7 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.46 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +31.11% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
